NCT06246851View on ClinicalTrials.gov

BCG Revaccination Study in Diabetic and Non-Diabetic Adults

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Tuberculosis
Interventions
BIOLOGICAL

BCG Danish

BCG Danish 1331 is on the WHO list of pre-qualified vaccines and has a well-defined side effect profile. BCG is licensed for delivery via the intradermal route. It is not licensed for delivery via the aerosol route.

Trial Locations (1)

OX3 7LE

RECRUITING

Centre for Clinical Vaccinology and Tropical Medicine, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER